CompletedNot Applicable

Bright Light Therapy on Sleep Health in Lung Cancer Patients

United States6 participantsStarted 2025-06-09

Plain-language summary

The goal of this randomized intervention trial is to determine the effect of bright light therapy on sleep disturbance, as well as to investigate the impacts of bright light therapy on biological age measured by clinical biomarkers. The main questions it aims to answer are: * Does bright light therapy improve sleep patterns (i.e., sleep onset latency, sleep disturbance, and sleep efficiency) in lung cancer patients? * Can bright light therapy slow the rate of aging measured by biological age in lung cancer patients? Researchers will compare bright light therapy group to control group to see if bright light works to reduce sleep disturbance and decelerate biological aging. Participants will: * Receive bright light exposure or usual light exposure every day for 4 weeks * Get blood draw at the baseline and at 4 weeks for clinical biomarkers tests * Complete self-reported sleep, fatigue and stress surveys at the baseline and at 4 weeks * Keep a daily sleep log

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * \>=18 years of age * Stage Ib to IIIb primary lung cancer diagnosis * \>=2 months after completion of primary therapy, patient can continue to be on maintenance/immunotherapy * ECOG performance status is 0 or 1 * Experience problematic sleep (scores of \>=8 on the Insomnia Severity Index) * Able to understand, speak, and read English * Sighted and mentally competent to consent Exclusion Criteria: * Pregnant women * Have metastatic cancer * on oxygen therapy * Current diagnosis of seasonal affective disorder or substance abuse * Engage in shift work or travel across \>3 time zones within 2 weeks prior to the study * Are currently being treated for sleep apnea, restless legs syndrome, or narcolepsy * Take prescribed sedative hypnotics or antipsychotics * Have eye conditions (glaucoma or retinal disease), problem triggered by bright light (e.g., migraine), or take photosensitizing medications (e.g., some porphyrin drugs, antipsychotics, antiarrhythmic agents) * Participants with an Insomnia Severity Index \<8 * Participants with cognitive impairment (sores of \<3 mini-cog test)

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change from Baseline in sleep patterns at 4 weeks

Timeframe: from enrollment to the end of the intervention at 4 weeks

Changes from baseline in the measures of biological age at 4 weeks

Timeframe: From enrollment to the end of intervention at 4 weeks

Trial details

NCT IDNCT07064395

SponsorHenry Ford Health System

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-03-31

View on ClinicalTrials.gov More Lung Cancers trials